Why isn't my medication working?

Has it had enough time

This is the most common reason a medication seems not to be working. The full effect builds slowly, and the early weeks rarely show it.

The fuller effect of an antidepressant usually takes about four to six weeks, and sometimes up to eight. Judging at two or three weeks is too early. The medication may well be working, just not far enough along yet to show. Some early changes, in sleep or appetite, can appear sooner, but the shift in mood itself is slower. That mismatch is part of why the first month can feel discouraging even when things are on track. Unless a prescriber advises otherwise, it's worth giving the medication the full planned trial before deciding it has failed.

Is the dose high enough

Antidepressants are often started at a low dose. That's deliberate, and it helps the body adjust to the medication with fewer side effects.

But a low starting dose is not always an effective dose. Many people need the dose raised to reach a level that actually treats their symptoms. A medication that seems not to work at a starting dose often just hasn't been adjusted yet. Raising the dose is a routine next step, and it's one of the first things a prescriber will consider when a first trial is underway and the response is thin.

Other reasons it might not be working

If time and dose have both been addressed, a prescriber will look at a few other things.

Missed or inconsistent doses can blunt the effect, so taking the medication regularly matters more than it might seem. The medication may not be the right fit, since response is individual and what works well for one person may not for another. The diagnosis may need a fresh look. For example, bipolar disorder is treated differently, and antidepressants alone don't work well for it. A contributing factor may be affecting mood, such as a thyroid problem, untreated sleep apnea, or ongoing heavy alcohol use, and treating that can change the picture. Side effects can make a medication hard to keep taking, which quietly limits how well it can work. And expectations matter, because medication can reduce symptoms but does not remove life stressors. A medication can lower the volume of depression while a difficult job or a strained relationship is still there.

What usually comes next

A prescriber has a clear set of options, and most of them are routine.

The choices, roughly in order, are giving the medication more time, raising the dose, switching to a different medication, adding a second medication, and adding therapy. Switching means stopping one antidepressant and moving to another, which has its own guide. Adding a second medication is another common route. Strictly speaking, augmentation means adding a medication that is not itself an antidepressant, such as lithium or an atypical antipsychotic, while adding a second antidepressant is called combination. The two terms describe different strategies, and a prescriber chooses between them based on the situation. Most people who don't respond to a first medication do respond to an adjusted plan. A first medication that doesn't work narrows things down and points to the next step.

Track your symptoms so progress is measured

It is easy to lose the thread of how things are going. Memory smooths over both the good days and the bad ones.

A simple written record fixes that. A line a day on mood, sleep, and side effects gives the prescriber something concrete at the next appointment, rather than a vague impression. Patterns are hard to see day to day but clear on paper across several weeks. Tracking also catches partial improvement that might otherwise go unnoticed, which can be the difference between staying the course and switching too soon. PsychiatryRx has a printable appointment sheet built for this.

What "treatment-resistant" means

This term describes depression that hasn't improved enough after two or more adequate medication trials. An adequate trial means a high enough dose for a long enough time, usually the full four to six weeks or more.

The label sounds final, but it isn't a verdict. It's a signal to broaden the approach rather than a dead end. At that point a prescriber can consider a wider range of strategies, and many people who reach this stage still improve. For difficult cases there are further options a prescriber can discuss, including treatments such as esketamine, a nasal spray used under supervision in clinic, and ECT, or electroconvulsive therapy, a procedure done under anesthesia. These are not first steps, and they are not the only steps, but they exist, and they help people. The point is that running out of easy options is not the same as running out of options.

Common questions

How long before I know it isn't working? Give it the full planned trial before concluding anything. The fuller effect usually takes four to six weeks, and sometimes eight, at an adequate dose. If there has been no meaningful change by then, that is a fair point to check in with the prescriber about a higher dose or a different medication. Earlier than that, the most likely answer is that the medication simply hasn't had enough time.

Can a medication stop working after it helped? Yes, this happens, and it has a few possible explanations. The dose may need adjusting, an untreated factor such as poor sleep or alcohol use may have crept in, or the underlying condition may have shifted. It is worth telling a prescriber rather than assuming the medication is finished. Often a change to the plan brings the benefit back.

What if nothing has worked? Several adequate trials without enough improvement is what "treatment-resistant" describes, and it is a signal to widen the approach, not to stop. That can mean combination or augmentation strategies, a fresh look at the diagnosis, adding therapy, or treatments like esketamine or ECT. A prescriber, ideally a psychiatrist, can map out what comes next. Many people in this situation still get better.

Sources

This guide draws on current prescribing information and public health references. It is reviewed for clinical accuracy and updated as guidance changes.

1. National Institute of Mental Health. Mental health medications.
2. MedlinePlus, U.S. National Library of Medicine.
3. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder.